An Open-Label Study to Determine the Safety and Efficacy of Alefacept as Monotherapy in Subjects With Chronic Plaque Psoriasis Who Have Failed to Respond to Anti-TNF Therapy.
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2013
At a glance
- Drugs Alefacept (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 21 Feb 2013 Last checked against ClinicalTrials.gov record.
- 29 Sep 2009 New trial record